Canaccord Genuity Downgrades PhotoMedex (PHMD) to Hold

Go back to Canaccord Genuity Downgrades PhotoMedex (PHMD) to Hold

Photomedex (PHMD) Misses Q2 EPS by 8c

August 7, 2014 8:49 AM EDT

Photomedex (NASDAQ: PHMD) reported Q2 EPS of $0.01, $0.08 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $52.1 million versus the consensus estimate of $62.1 million.

For earnings history and earnings-related data on Photomedex (PHMD) click here.

... More